Rivista in lingua italiana
riservata ai Soci SISA
Ultimo numero:
Anno 17 • N.1/2026
OBJECTIVE: To examine the relationship between ectopic adiposity and markers of cardiometabolic risk, autonomic control, and subclinical cardiovascular disease (CVD).
METHODS: Cross-sectional analyses were performed in 324 subjects with overweight and obesity. Single-slice CT images were analyzed to calculate thigh muscle attenuation (MA), a measure of ectopic adiposity. Autonomic control was assessed using low-frequency to respiratory-frequency heart rate variability (LFa/RFa ratio). Carotid intima-media thickness (IMT) was a marker of subclinical CVD.
RESULTS: Among overweight participants, those with low MA had lower HDL-c, higher LFa/RFa ratio, and subcutaneous thigh fat compared to high MA individuals despite no difference in visceral fat or insulin resistance. Significant associations were not observed in the class I obese group. In the class II obese group, those with high MA had higher triglycerides and insulin levels, yet there was no difference in visceral fat compared to the low MA group. Mean IMT was significantly higher in the low MA compared to the high MA overweight group (0.63 mm vs. 0.58 mm, P = 0.04) but was similar between the low and high MA class II obese groups.
CONCLUSIONS: Excess ectopic adiposity in muscle tissue is associated with metabolic and autonomic risk factors and subclinical CVD, most notably in overweight individuals, independent of insulin resistance and visceral abdominal fat.
Obesity (Silver Spring). 2015;23:2030-6
40° Congresso NazionaleLazise (VR), 21-23 novembre 2026
Save the Date

Spring Meeting Giovani Ricercatori SID, SIGG, SIIA, SIMI, SIPREC, SISARimini, 19-21 aprile 2026
[continua a leggere]
Congresso Sezioni SISA Adriatica e SIIA Umbro-MarchigianaAncona, 16 Dicembre 2025
[continua a leggere]
V.A.S.I. Vasculopatie Aterosclerotiche a Sfondo Internistico - V EdizionePerugia, 5 Dicembre 2025
[continua a leggere]
Rivista in lingua italiana
riservata ai Soci SISA
Ultimo numero:
Anno 17 • N.1/2026
Rivista Italiana della
Ipercolesterolemia
Familiare Omozigote
Anno 7 • N.1/2025

Nuovo sito dedicato al Progetto LIPIGEN
Progetto LIPIGEN - Vecchio portale
E' necessario essere loggati come utente
Lipigen per poter accedere alla pagina
PROSISA – PROject Statin Intolerance SISA
E' necessario essere loggati come utente
PROSISA per poter accedere alla pagina
Gruppo Interdisciplinare Lipoprotein Aferesi
(Accesso Gruppo GILA-Lipoprotein Aferesi)
E' necessario essere loggati come utente del Gruppo GILA per poter accedere
Gruppo Interdisciplinare Lipoprotein Aferesi
(Documentazione ad accesso libero)
Pagina informativa per medici e pazienti